Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Veeva Systems's accounts receivables for the quarter that ended in Jul. 2026 was $497 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Veeva Systems's Days Sales Outstanding for the quarter that ended in Jul. 2026 was 48.84.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Veeva Systems's Net-Net Working Capital per share for the quarter that ended in Jul. 2026 was $36.99.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Veeva Systems's Days Sales Outstanding for the quarter that ended in Jul. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Veeva Systems's accounts receivable are only considered to be worth 75% of book value:
Veeva Systems's Net-Net Working Capital Per Share for the quarter that ended in Jul. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Veeva Systems Accounts Receivable Related Terms
Veeva Systems Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (VEEV) has a Accounts Receivable of $497 Mil as of Jul. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Veeva Systems and its competitors.
Is Veeva Systems' Accounts Receivable too high?
Veeva Systems' current Accounts Receivable is $497 Mil. Overall, Veeva Systems has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Accounts Receivable compare to BTSG and TEM?
Veeva Systems' Accounts Receivable of $497 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Veeva Systems and its competitors. Veeva Systems's current Accounts Receivable is $497 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Modestly Undervalued. The stock's GF Value™ is $290.82, compared to a current price of $262.40 — trading 9.8% below its estimated fair value. The current Accounts Receivable is $497 Mil. Veeva Systems' overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Veeva Systems (VEEV), the current Accounts Receivable is $497 Mil as of Jul. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $262.40 is trading 9.8% below its estimated GF Value™ of $290.82.
GuruFocus considers Veeva Systems to be Modestly Undervalued.
Key valuation signals for VEEV:
Accounts Receivable: $497 Mil
GF Value™: $290.82 vs. price of $262.40 (9.8% below fair value)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
99GF Score
Get the complete analysis for VEEV
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
